肝细胞癌
医学
内科学
胃肠病学
射频消融术
糖尿病
丙型肝炎病毒
多元分析
乙型肝炎病毒
乙型肝炎
丙型肝炎
回顾性队列研究
肿瘤科
烧蚀
病毒
免疫学
内分泌学
作者
Wei-Ting Chen,Therese Capalongan Macatula,Chun-Yen Lin,Chun-Jung Lin,Shi-Ming Lin
出处
期刊:PubMed
日期:2011-06-15
卷期号:58 (106): 551-7
被引量:3
摘要
Diabetes mellitus (DM) is prevalent in patients with hepatocellular carcinoma (HCC) but its effects on post-radiofrequency ablation (RFA) have not been elucidated. This study aims to determine whether DM significantly impacts the outcomes in patients with HCC after RFA.This retrospective study included 161 HCC patients successfully treated with RFA. Intra-hepatic HCC recurrence and survival were analysed.No significant difference was found for 1-, 2-, 3- year's intra-hepatic HCC recurrence rates (DM: 45%, 61%, 74% vs. non-DM: 42%, 62%, 75%;p=0.935) and survival rates (DM: 83%, 80%, 73% vs. non-DM: 92%, 84%, 79%; p=0.218) between diabetics (53 patients) and non-diabetics (108 patients). In subgroup analysis of viral etiology and HCC, no significant difference was noted for intra-hepatic HCC recurrence or survival in hepatitis B virus-related or hepatitis C virus-related HCC. Multivariate analysis showed only persistent hepatitis influenced intra-hepatic HCC recurrence (p=0.021) and survival (p=0.022).DM may not affect the intra-hepatic HCC recurrence and survival in patients with HCC after RFA. However, persistent hepatitis after RFA may affect intra-hepatic HCC recurrence and survival.
科研通智能强力驱动
Strongly Powered by AbleSci AI